Despite the uncertain prospects as a result of rising geopolitical tensions and the impact of protectionist policy, the Canadian stock markets have witnessed healthy purchases in recent months, which has stimulated the ratings of Canadian companies higher. However, the following two Canadian shares are still acting towards more attractive valuations and offer fascinating buying options.
Telus
After a challenging for a few years, the Canadian telecom companies experience a healthy question this year, in the midst of an environment with a low interest rate and the increasing demand for telecommunications services. Years to date, Telus (TSX: T) has witnessed an increase in the stock price of 20.7%. Despite the recent increases, it is still being traded with a considerable discount compared to its 2022 highlights. The NTM (next 12 months) are also price-to-sales and NTM price-to-win multiples, 1.7 and 21.4 respectively, which look reasonable.
In addition, Telus is planning to invest around $ 70 billion in the coming five years to expand and improve its network infrastructure and connectivity. Currently, broadband connectivity offers 3.5 million customers, while the 5G services cover 88% of the population of the country. These extensions can help to grow his customer base and stimulate his financial data.
Moreover, the segment in health care, Telus Health, continues to experience healthy growth through strategic investments, new product launches and the expansion of its sales channels. It has also improved its profitability by effectively managing costs by approving technological progress and synergy optimization.
In the meantime, by the end of 2027, Telus is working on reducing his lever ratio to three, with the ratio in the second quarter falling by 20 basic points to 3.7. It has also signed an agreement to sell 49.9% of the importance in its wireless tower infrastructure activities to La Caisse for $ 1.26 billion, which could help to further reduce his leverage.
In particular, the Telecombedrijf -based telecom company has rewarded its shareholders by increasing its dividend 28 times since initiating his dividend growth program in May 2011. The forward dividend yield is currently a healthy 7.34%. Given all these factors, I believe that Telus would be an excellent purchase at these levels.
Good health technologies
Another undervalued Canadian shares I am bullish about is Good health technologies (TSX: Well), who has lost more than 32% of his stock value this year. Skepticism of investors has grown in the midst of the ongoing investigation into the invoicing practices of its subsidiary, Circle Medical, resulting in a significant correction. The sale has dragged its appreciation down, whereby the company is currently being traded against the expected sales and income of analysts of 0.8 and 11 times analysts.
In the meantime, the HealthTech Company, based in Vancouver last month, reported a solid performance of the second quarter, with its top line and adapted income before interest, taxes, depreciation and amortization grow by 57% and 231% respectively.
Furthermore, the digitization of clinical procedures and the growing acceptance of long -term virtual services have created growth potential for PUT Health. In the meantime, the company continues to invest in artificial intelligence to develop innovative products, which could help expand its market share. Moreover, the company continues to expand its company through strategic acquisitions. After completing 14 acquisitions this year from 14 August, the company had signed 15 intent letters, which could increase its annual turnover by $ 134 million. That is why the growth prospects look healthy.
#undervalued #Canadian #shares #prepared #great #efficiency